Bile acids, principally deoxycholic acid (DCA), have been implicated in the
promotion of colon tumorigenesis in both animals and humans, Increasing ev
idence suggests that bile acids may exert their tumor promoting activity by
modulating intracellular signaling and altering gene expression. In this s
tudy we have investigated the effect of bile acids on the tumor suppressor
p53 using the human colon tumor cell line HCT116, which retains the wild-ty
pe p53 gene and functional p53 signaling in response to DNA damage. We foun
d that exposure of the cells to elevated concentrations of DCA suppressed a
ccumulation of p53 protein as well as p53 transactivation and impaired the
p53 response of the cells to DNA damaging agents, such as ionizing radiatio
n. Neither ursodeoxycholic acid, a putative chemopreventive agent, nor chol
ic acid, which is biologically inert, had any effect on p53 protein level a
nd transactivation activity. Further examination revealed that instead of i
nhibition, DCA induced p53 mRNA in a dose-dependent manner, indicating that
the inhibitory effect of DCA on p53 protein is mediated by a post-transcri
ptional mechanism, Both lactacystin, a specific inhibitor of the 26S protea
some, and leptomycin B, a specific inhibitor of the nuclear export protein
CRM1, could block the effect that DCA had on p53 protein levels, suggesting
that DCA suppressed p53 by stimulating the process of proteasome-mediated
degradation of p53, Significantly, blocking extracellular signal-regulated
kinase (ERK) signaling, but not protein kinase C (PKC), blunted suppression
by DCA of p53 protein levels and transactivation activity, suggesting that
DCA suppressed p53, in part, by stimulating the ERK signaling pathway. Bot
h ERK and PKC signaling have been previously demonstrated to be stimulated
by DCA, These results suggest a novel signaling mechanism of bile acids tha
t may play an important role in colon tumor promotion mediated by bile acid
s.